Stryker Corporation was incorporated in Michigan in 1946. It is a medical technology company. The Company offers medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. Its business segments are Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics products consist of implants used in hip and knee joint replacements and trauma and extremities surgeries. The Company supports surgeons with the technology and services needed as the company develops new surgical techniques. The MedSurg products include surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical); and reprocessed and remanufactured medical devices (Sustainability) as well as other medical device products used in a variety of medical specialties. The Neurotechnology and Spine products include both neurosurgical and neurovascular devices. Its neurotechnology offering includes products used for minimally invasive endovascular techniques; a comprehensive line of products for traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also develops, manufacture and market spinal implant products including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. The Company's competitors include Zimmer Holdings, Inc. (Zimmer), DePuy Synthes Company, a subsidiary of Johnson & Johnson, Biomet, Inc.,Smith & Nephew plc (Smith & Nephew), Medtronic, including Covidien. The Company's businesses are subject to varying degrees of governmental regulation in the countries in which the company operates and the general trend is toward increasingly stringent regulation.